GDT Ontario Health Testing Eligibility
HCT v3
GTD Indications
Diagnosis
Carrier / Cascade Testing
GTD Samples Accepted
Blood
DNA
Cultured Cells
Saliva
Tissue
GTD Test Methodology
CNV
Sequencing
GTD Methodology Notes
Targeted Mutation
Generic Test name (cms title)
Ashkenazi Jewish Panel
GTD Test type
Targeted Variant
GTD Location
North York General Hospital
GTD Gene/Platform/Region List
APC NM_000038.6 c.3920T>A (p.Ile1307Lys) (APC I1307K), BRCA1 NM_007294.3 c.68_69del (p.Glu23Valfs*17) 185delAG, BRCA2 NM_000059.3 c.5946del (p.Ser1982Argfs*22) 617delT, CHEK2 NM_007194.3 c.1283C>T (p.Ser428Phe) c.620C>T NM_001257387, GREM1 NM_013372.6 CNV analysis, MSH2 NM_000251.2 c.1906G>C (p.Ala636Pro) A636P, MSH6 NM_000179.2 c.3984_3987dupGTCA (p.Leu1330Valfs*12)
GTD Category
Cancer
GTD Disease/Condition
Ashkenazi Jewish Panel